Saldent Internacional S.r.l., Pharmaceutical Import Profile — Dominican Republic (DGFT 2022–2026)

Name: Saldent Internacional S.r.l., Pharmaceutical Import Records from India — 4 Products, $4.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Saldent Internacional S.r.l., — Pharmaceutical Importer Profile (2026) | 4 Products, $4.5M Trade | TransData Nexus

Saldent Internacional S.r.l.,

Pharmaceutical Importer · Dominican Republic · Antifungals Focus · $4.5M Total Trade · DGFT Verified

Saldent Internacional S.r.l., is a pharmaceutical importer based in Dominican Republic with a total trade value of $4.5M across 4 products in 3 therapeutic categories. Based on 131 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Saldent Internacional S.r.l., sources from 2 verified Indian suppliers, with Caplin Point Laboratories Limited accounting for 99.3% of imports.

Saldent Internacional S.r.l., — Import Portfolio & Supplier Network

Saldent Internacional S.r.l., import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Saldent Internacional S.r.l.,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$7.7M	437	99.3%
Argus Salud Pharma Llp	$52.3K	6	0.7%

Saldent Internacional S.r.l., sources from 2 verified Indian suppliers across 262 distinct formulations.

What Formulations Does Saldent Internacional S.r.l., Import?

Formulation	Value	Ships
Gencloben 30g (gentamycin	$250.0K	5
Ampicillin tablets USP 1000MG	$250.0K	5
Cevitran (vitamin c chewable tablets	$198.5K	5
Clarithromycin tablets USP 500MG claritromicina tabletas recubiertas 500MG (coclarit 500) (claritromicina USP 500MG)	$192.0K	7
Gencloben 30g (gentamycin	$150.0K	3
Gencloben (gentamycin, betamethasone, clotrimazole cream) gencloben 30g (gentamicina +betametasona + clotrimazol crema)	$140.9K	6
Clarithromycin tablets USP 500MG	$137.9K	3
Vitamin c chewable tablets 500MG (cevitran) cevitran vitamina c (sabor a naranja) acido ascorbico tabletas	$132.5K	3
Sterilised water for injection BP 10ML	$131.7K	5
Carbamazepine tablets BP 200MG	$121.8K	3
Metronidazole + nystatin vaginal	$114.0K	5
Azithromycin for oral suspension USP 200MG/5ML azitromicina polvo para suspension oral 200MG/5ML 30ML (azitromicina	$113.1K	6
Gencloben (gentamycin betamethasone clotrimazole cream) gencloben 30g(gentamicina +betametasona + clotrimazol crema	$109.7K	3
Vitamin e capsules USP 1000 IU -	$100.0K	2
Propofol injectable emulsion USP 1%	$100.0K	2

Saldent Internacional S.r.l., imports 262 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Clotrimazole	Antifungals	$1.7M	41	1.8%	5
2	Gentamicin	Antibiotics	$1.7M	35	2.4%	5
3	Vitamin	Nutritional Supplements	$842.5K	34	0.6%	18
4	Nystatin	Antifungals	$312.6K	21	0.6%	14

Saldent Internacional S.r.l., imports 4 pharmaceutical products across 3 categories into Dominican Republic totaling $4.5M.

Saldent Internacional S.r.l., — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Saldent Internacional S.r.l. is a prominent pharmaceutical importer based in the Dominican Republic, specializing in the acquisition of finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. The company plays a pivotal role in the nation's pharmaceutical distribution network, ensuring the availability of essential medications across various therapeutic categories. Headquartered in Santo Domingo, Saldent Internacional S.r.l. operates as an independent entity without a publicly known parent company. Its strategic focus on importing a diverse range of pharmaceutical products underscores its commitment to meeting the healthcare needs of the Dominican population.

2Distribution Network

While specific details about Saldent Internacional S.r.l.'s warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive import activities suggest a well-established distribution network within the Dominican Republic. The 131 shipments from India indicate a robust logistical framework capable of handling significant volumes of pharmaceutical products. This infrastructure likely supports comprehensive geographic coverage, ensuring timely and efficient delivery of medications to various regions within the country.

3Industry Role

Saldent Internacional S.r.l. functions primarily as a pharmaceutical importer and wholesaler within the Dominican Republic's supply chain. By sourcing finished pharmaceutical formulations from international suppliers, the company bridges the gap between global manufacturers and local healthcare providers. Its role is crucial in maintaining a steady supply of essential medications, thereby supporting the operational needs of hospitals, clinics, pharmacies, and other healthcare institutions across the nation.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Saldent Internacional S.r.l.,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with 99.3% of its imports originating from a single supplier, Caplin Point Laboratories Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent volume of shipments—437 in total—suggests a stable and well-established relationship between Saldent Internacional S.r.l. and Caplin Point Laboratories Limited. The remaining 0.7% of imports from Argus Salud Pharma LLP indicates minimal diversification in sourcing.

2Supply Chain Resilience

The resilience of Saldent Internacional S.r.l.'s supply chain is closely tied to its reliance on Caplin Point Laboratories Limited. The absence of backup suppliers for the majority of its imports suggests potential vulnerabilities in the event of disruptions. Additionally, the limited diversity in imported formulations, with 262 unique products, may impact the company's ability to adapt to changing market demands. The shipping routes primarily from India to the Dominican Republic are well-established, but any geopolitical or logistical challenges could affect supply continuity. Regulatory compliance of Caplin Point Laboratories Limited, adhering to standards such as WHO GMP, is essential to ensure the quality and safety of imported products.

Importing Pharmaceuticals into Dominican Republic — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Dominican Republic

1Regulatory Authority & Framework

The Dominican Republic's pharmaceutical imports are regulated by the Ministry of Public Health and Social Assistance, specifically the Department of Drugs and Pharmacies (SESPAS). Key legislation includes the General Law on Health and Regulation No. 246-06 on Medicines, which govern the importation of pharmaceuticals, cosmetics, and personal hygiene products. Pharmaceuticals classified as prescription psychotropic substances or subject to Law No. 50-88 on Drugs and Controlled Substances are also covered by this legislation. Importers must obtain an import permit from SESPAS for controlled medicines, semi-finished products, raw materials, solvents, and precursor chemicals.

2Import Licensing & GMP

Import licensing requirements in the Dominican Republic stipulate that pharmaceutical products must be registered with the Ministry of Public Health. A Sanitary Register must be obtained for each trademark or product imported, valid for five years. Additionally, Good Manufacturing Practices (GMP) certification is mandatory, with recognition of EU GMP, WHO GMP, and PIC/S standards. Importers must ensure that their suppliers comply with these certifications to facilitate the import process.

Quality & Labeling

Saldent Internacional S.r.l., — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Saldent Internacional S.r.l. focuses on importing products in the antifungal, antibiotic, and nutritional supplement categories, which constitute 44.3%, 37.2%, and 18.5% of its imports, respectively. This strategic focus aligns with the prevalent health concerns in the Dominican Republic, where infections and nutritional deficiencies are common. The demand for these products is driven by the need to address public health challenges, making them essential components of the country's healthcare system.

2Sourcing Profile

The company's sourcing strategy is heavily centered on generic drugs, primarily sourced from India. This approach allows Saldent Internacional S.r.l. to offer cost-effective solutions to the Dominican market while maintaining a diverse product portfolio. The preference for finished pharmaceutical formulations ensures that the company can meet the immediate needs of healthcare providers without the complexities associated with raw material imports.

3Market Positioning

Based on its product mix, Saldent Internacional S.r.l. serves a broad segment of the Dominican Republic market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. The company's diverse product offerings enable it to cater to various healthcare needs, positioning it as a key player in the pharmaceutical supply chain.

Seller's Guide — How to Become a Supplier to Saldent Internacional S.r.l.,

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Dominican market by offering competitive pricing, reliable quality, and adherence to international regulatory standards. Gaps in Saldent Internacional S.r.l.'s current sourcing include a limited supplier base and a narrow range of imported formulations. Diversifying the supplier base and expanding the product range could enhance the company's resilience and competitiveness.

2Requirements & Qualifications

Indian exporters seeking to supply Saldent Internacional S.r.l. and the Dominican Republic market must obtain GMP certifications recognized by the Dominican authorities, such as EU GMP, WHO GMP, or PIC/S. Additionally, they must ensure that their products are registered with the Ministry of Public Health and comply with labeling and serialization requirements. Maintaining high-quality standards and adhering to regulatory guidelines are essential for successful market entry.

3How to Approach

Frequently Asked Questions — Saldent Internacional S.r.l.,

What products does Saldent Internacional S.r.l., import from India?

Saldent Internacional S.r.l., imports 4 pharmaceutical products across 3 categories. Top imports: Clotrimazole ($1.7M), Gentamicin ($1.7M), Vitamin ($842.5K), Nystatin ($312.6K).

Who supplies pharmaceuticals to Saldent Internacional S.r.l., from India?

Saldent Internacional S.r.l., sources from 2 verified Indian suppliers. The primary supplier is Caplin Point Laboratories Limited (99.3% of imports, $7.7M).

What is Saldent Internacional S.r.l.,'s total pharmaceutical import value?

Saldent Internacional S.r.l.,'s total pharmaceutical import value from India is $4.5M, based on 131 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Saldent Internacional S.r.l., focus on?

Saldent Internacional S.r.l., imports across 3 categories. The largest: Antifungals (44.3%), Antibiotics (37.2%), Nutritional Supplements (18.5%).

Get Full Saldent Internacional S.r.l., Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.